세계의 환자 참여 솔루션 시장 : 구성 요소별, 전달 방법별, 치료 영역별, 기능별, 최종 사용자별, 미충족 요구, 투자, 구매 기준-예측(-2028년)

Patient Engagement Solutions Market by Component (Hardware), Software, Therapy, Functionality, User (Provider, Payer), Unmet Need, Investment, Buying Criteria - Global Forecast to 2028

US $ 4,950 ￦ 7,241,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,728,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,923,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,630,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 개요

조사 범위
조사 대상 연도	2021-2028년
기준 연도	2022년
예측 기간	2023-2028년
단위	금액(100만 달러)
부문	구성 요소, 전달 방법, 치료 영역, 용도, 기능, 최종 사용자, 지역
대상 지역	북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카

세계의 환자 참여 솔루션(Patient Engagement Solutions) 시장 규모는 2023년에 225억 달러였으며, 2028년까지 418억 달러에 달할 것으로 예상되며 예측 기간 동안 CAGR로 13.2%로 추이하며 성장 할 것으로 예상됩니다.

환자 참여 솔루션에 대한 수요 증가와 모바일 헬스 앱 사용 증가 등 요인이 시장 성장을 가속하고 있습니다.

그러나 의료 인프라에 대한 높은 투자 요건과 의료 업계에서 숙련된 IT 전문가의 부족이 예측 기간에 시장 성장을 억제할 전망입니다.

'서비스 부문이 2023-2028년에 가장 높은 성장률로 성장할 것으로 예측됩니다.'

구성 요소에 따라 환자 참여 솔루션 시장은 소프트웨어, 하드웨어 및 서비스로 나뉩니다. 소프트웨어 부문은 2022년에 시장에서 가장 큰 점유율을 차지합니다. 통합 솔루션 부문은 2022년 시장에서 큰 점유율을 차지했으며, 예측 기간에 가장 높은 CAGR을 나타낼 전망입니다.

하지만 서비스 부문이 2023년부터 2028년까지 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 서비스 부문의 현저한 성장은 가치 기반 환자 중심 케어를 제공하는 혁신적인 서비스 모델 개발에 대한 투자가 증가하고 시장 성장을 가속하는 등으로 인한 것으로 예상됩니다.

'온프레미스 솔루션 부문이 2023년 시장을 독점할 것으로 예측됩니다.'

온프레미스 솔루션 부문이 2023년 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 그러나 2023년부터 2028년까지 클라우드 기반/웹 기반 방식 부문이 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 이 부문의 큰 점유율은 시장에서 클라우드 기반 솔루션에 고유한 유연성, 확장성, 합리적인 가격의 특징으로 인한 성장 지원으로 인한 것입니다.

'2022년 용도별로는 건강 관리 부문이 시장에서 가장 큰 점유율을 차지했습니다.'

2023년, 건강 관리 부문은 시장에서 가장 큰 점유율을 차지합니다. 건강상태에 대한 환자의 의식의 고조가 시장 성장의 촉진 요인이 되고 있습니다.

'2022년 치료 영역별로 만성 질환이 시장에서 가장 큰 점유율을 차지했습니다.'

2022년 만성 질환 부문이 시장을 독점했으며 만성 질환 중 심혈관 질환 부문이 시장에서 가장 큰 점유율을 차지했습니다. 그러나 세계에서 당뇨병의 유병률과 발병률이 높기 때문에 당뇨병 부문이 예측 기간에 가장 높은 CAGR을 기록할 전망입니다.

'기능별로 환자/클라이언트 스케줄링이 시장에서 최대 점유율을 차지했습니다.'

기능별로 환자/클라이언트 스케줄링 부문은 2022년 시장에서 가장 큰 점유율을 차지합니다. 환자/클라이언트 스케줄링 부문의 큰 점유율은 주로 환자의 품질 치료를 낮은 비용으로 환자에게 제공하기 위해 환자 참여 소프트웨어의 채택을 촉진하는 정부 노력 증가로 인한 것입니다.

'최종 사용자별로 제공업체 부문은 2022년 최대 점유율을 차지했습니다.'

이 부문의 큰 점유율은 증가하는 의료 비용을 억제하고, 가치 기반 케어를 제공하며, 재무 성과를 확대하기 위한 환자 참여 솔루션의 도입 증가로 인한 것입니다.

'2022년 북미가 환자 참여 솔루션 시장을 독점했습니다.'

유리한 정부의 이니셔티브와 규제, 의료 비용 절감의 필요성, 만성 질환 증가, 주요 시장 기업의 존재 등 요인이 북미 시장의 성장에 크게 기여하고 있습니다.

아시아 태평양 시장은 2023-2028년의 예측기간에 가장 높은 CAGR을 달성할 전망입니다. 이 성장은 의료 IT(HCIT) 솔루션의 채택 확대와 이 지역의 만성 질환의 유행에 기인합니다. 환자 수 증가와 정확하고 시기 적절한 진단 및 치료에 대한 필요성 증가는 예측되는 아시아 태평양 시장의 성장에 더욱 기여합니다.

세계의 환자 참여 솔루션(Patient Engagement Solutions) 시장에 대해 조사 분석 했으며, 주요 촉진 요인 및 억제 요인/경쟁 구도/향후 동향 등 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

• 환자 참여 솔루션 시장의 기업에게 매력적인 기회
• 북미의 환자 참여 솔루션 시장 : 전달 방법별, 국가별(2022년)
• 환자 참여 솔루션 시장 : 지리적 성장 기회
• 환자 참여 솔루션 시장 : 지역 구성
• 환자 참여 솔루션 시장 : 선진국 VS. 신흥 경제국

제5장 시장 개요

• 소개
• 시장 역학
  • 성장 촉진 요인
  • 억제 요인
  • 기회
  • 과제
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 산업 동향
• 생태계 분석
• 밸류체인 분석
  • 연구개발
  • 재료 구성 요소
  • 제조업체, 개발자
  • 유통, 판매
  • 최종 용도 산업
  • 판매 후 서비스
• 기술 분석
  • AI, ML
  • VR, AR
  • 원격 모니터링 장비, 웨어러블
• 관세 및 규제 분석
  • 규제 기관, 정부 기관, 기타 조직
  • 북미
  • 유럽
  • 아시아 태평양
  • 남미
  • 중동 및 아프리카
• 가격 분석
  • 가격 개요
  • 주요 기업의 평균 판매 가격 동향 : 용도별
  • 환자 참여 솔루션의 참고 가격 분석
• 무역 분석
• Porter's Five Forces 분석
• 특허 분석
• 주요 이해관계자와 구매 기준
• 최종 사용자 분석
  • 언멧 요구
  • 최종 사용자의 기대
• 주된 회의와 이벤트(2023-2024년)
• 환자 참여 솔루션의 대체 동향
• 환자 참여 솔루션에 대한 투자 상황
• 환자 참여 솔루션의 비즈니스 모델
• 이용 사례/케이스 스터디

제6장 환자 참여 솔루션 시장 : 구성 요소별

• 소개
• 하드웨어
• 소프트웨어
• 서비스

제7장 환자 참여 솔루션 시장 : 전달 방법별

• 소개
• 온프레미스 모드
• 클라우드 기반/웹 기반 방식

제8장 환자 참여 솔루션 시장 : 용도별

• 소개
• 건강 관리
• 가정 건강 관리
• 사회·행동 관리
• 재무 건전성 관리

제9장 환자 참여 솔루션 시장 : 치료 영역별

• 소개
• 만성 질환
  • 심혈관질환(CVD)
  • 당뇨병
  • 비만
  • 기타 만성질환
• 여성 건강
• 피트니스
• 기타 치료 영역

제10장 환자 참여 솔루션 시장 : 기능별

• 소개
• 환자/클라이언트 스케줄링
• 원격 의료
• 전자 처방
• 문서 관리
• 청구·결제
• 환자 교육
• 기타 기능

제11장 환자 참여 솔루션 시장 : 최종 사용자별

• 소개
• 제공업체
• 보험자
• 환자
• 기타 최종 사용자

제12장 환자 참여 솔루션 시장 : 지역별

• 소개
• 북미
  • 경기 후퇴의 영향
  • 미국
  • 캐나다
• 유럽
  • 경기 후퇴의 영향
  • 독일
  • 프랑스
  • 영국
  • 스페인
  • 이탈리아
  • 기타 유럽
• 아시아 태평양
  • 경기 후퇴의 영향
  • 일본
  • 중국
  • 인도
  • 기타 아시아 태평양
• 남미
  • 경기 후퇴의 영향
  • 브라질
  • 멕시코
  • 기타 남미
• 중동 및 아프리카
  • 경기 후퇴의 영향
  • GCC 국가
  • 기타 중동 및 아프리카

제13장 경쟁 구도

• 개요
• 주요 기업의 전략/유력 기업
• 수익 분석
• 시장 점유율 분석
• 기업의 평가 매트릭스
• 스타트업/중소기업 평가 매트릭스
• 경쟁 구도, 동향

제14장 기업 개요

• 주요 기업
  • MCKESSON CORPORATION
  • ORACLE CORPORATION
  • VERADIGM LLC
  • ATHENAHEALTH
  • ORION HEALTH
  • GETWELLNETWORK, INC.
  • LINCOR INC.
  • COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
  • GET REAL HEALTH
  • ONEVIEW HEALTHCARE
  • ADVANCEDMD, INC.
  • EPIC SYSTEMS CORPORATION
  • HARRIS HEALTHCARE
  • MEDICAL INFORMATION TECHNOLOGY, INC.
• 기타 기업
  • KAREO, INC.
  • ECLINICAL WORKS
  • WELLSTACK
  • IQVIA HOLDINGS INC.
  • VIVIFY HEALTH
  • MEDHOST
  • LUMA HEALTH
  • CUREMD HEALTHCARE
  • SONIFI HEALTH
  • ADVANTECH CO., LTD.
  • BARCO

제15장 부록

LYJ

영문 목차

영문목차

Report Description

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	Value (USD) Million
Segments	Component, Delivery Mode, Therapeutic Area, Application, Functionality, End User, And Region
Regions covered	North America, Europe, Asia Pacific, Latin America and Middle East & Africa

The patient engagement solutions market is projected to reach USD 41.8 billion by 2028 from USD 22.5 billion in 2023, at a CAGR of 13.2% during the forecast period. Factors such as the growing demand for patient engagement solutions and the increasing utilization of m-health apps are driving the market growth.

However, high investment requirements for healthcare infrastructure and the scarcity of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

"Services segment is expected to grow at the highest rate from 2023 to 2028."

By components, the patient engagement solutions market is divided into software, hardware, and services. The software segment holds the largest share of the global patient engagement solutions market in 2022. The hardware is further segmented into in-room televisions, integrated bedside terminals/assisted devices and tablets. The software market is further divided into standalone software and integrated software. In 2022, the integrated solutions segment holds the larger share of this market & is also projected to grow at the highest CAGR during the forecast period.

Nevertheless, the services segment is projected to exhibit the highest CAGR from 2023 to 2028. The notable growth in the services segment can be attributed to factors such as the increasing investments in the development of innovative service models that offer value-based, patient-centered care, driving the market growth for services.

"The on-premise solutions segment is anticipated to dominate the Patient Engagement Solutions market in 2023."

When considering delivery modes, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes. In 2023, it is projected that the on-premise solutions segment will command the largest share of the global patient engagement solutions market. However, the cloud-based/web-based mode segment is forecasted to exhibit the highest CAGR from 2023 to 2028. The substantial share of this segment can be attributed to the growth support provided by the flexibility, scalability, and affordability features inherent in cloud-based solutions within the patient engagement solutions market.

"In 2022, the Health management segment accounted for the largest share of the global patient engagement solutions market, by applications."

By application, the patient engagement solutions market is divided into health management, home health management, social and behavioral management, and financial health management. In 2023, the health management applications segment accounts for the largest share of the global patient engagement solutions market. Health management includes a wide range of patient engagement tools that help patients engage with their providers and take initiatives to improve or maintain their health status and increased awareness among patients about health conditions are the factors driving market growth.

"In 2022, Chronic diseases accounted for the largest share of the global patient engagement solutions market by therapeutic area."

By therapeutic area, the patient engagement solutions market is divided into chronic diseases (cardiovascular disease, diabetes, obesity and other chronic diseases), women's health, fitness, and other therapeutic areas. The chronic diseases segment dominated this market in 2022. In 2022, the cardiovascular diseases segment accounted for the largest share of the patient engagement solutions market for chronic diseases. However, the diabetes segment is projected to register the highest CAGR during the forecast period, owing to the high prevalence and incidence of diabetes worldwide.

"Patient/client scheduling accounted for the largest share of the global patient engagement solutions market, by functionality."

By functionality, the patient engagement solutions market is divided into E-prescribing, document management, telehealth, patient/client scheduling, patient education, billing & payments and other functionalities. The patient/client scheduling segment accounted for the largest share of the patient engagement solutions market, by functionality, in 2022. The large share of the patient/client scheduling segment is mainly attributed to increasing government initiatives to boost patient engagement software adoption to provide quality care by physicians to their patients at lower costs.

"Providers' segment accounted for the largest share of the global patient engagement solutions market by end user in 2022."

By end users, the patient engagement solutions market is divided into providers, payers, patients, and other end users. The providers are further bifurcated into hospitals and healthcare systems, ambulatory care centers, home healthcare, and other providers. Moreover, the payers are further divided into private and public. By end users, the providers segment accounted for the largest share of the global patient engagement solutions market in 2022. The large share of this segment is due to the increasing implementation of patient engagement solutions to curtail mounting healthcare costs, offer value-based care, and expand financial outcomes are factors that are driving the growth of this segment.

"North America to dominate the patient engagement solutions market in 2022."

In 2022, North America dominated the global patient engagement solutions market by region. Factors such as favorable government initiatives and regulations, the imperative to reduce healthcare costs, the increasing prevalence of chronic diseases, and the presence of key market players contribute significantly to the growth of the patient engagement solutions market in North America.

The Asia Pacific market is expected to achieve the highest CAGR during the forecast period from 2023 to 2028. This growth is attributed to the escalating adoption of Healthcare Information Technology (HCIT) solutions and the increasing prevalence of chronic diseases in the region. The rising patient volume and the growing need for accurate and timely diagnosis and treatment further contribute to the anticipated growth of the patient engagement solutions market in the Asia Pacific region.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Region: North America (46%), Europe (26%), Asia Pacific (18%), Latin America (7%), and Middle East & Africa (10%)

McKesson Corporation (US), Veradigm (US), Oracle Corporation (US), Merative (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), Luma Health Inc. (US), WellStack(US), Vivify Health (US), Medhost (US), MEDISYSINC (US), and Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage

• The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total patient engagement solutions market.
• The report forecasts the revenue of market segments with respect to five majors regions.

Reasons to Buy the Report

• This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (implementation of government regulations and initiatives to promote patient centric care, increasing adoption of patient engagement solutions, rising number of collaborations and partnerships between stakeholders, increasing utilization of mobile health apps), restraints (large investment requirement for healthcare infrastructure, protection of patient information, inadequate interoperability across healthcare providers and shortage of skilled IT professionals in the healthcare industry ), opportunities (growth opportunities in emerging markets, wearable health technology, cloud computing solutions), and challenges (high deployment cost of healthcare IT systems, low levels of healthcare literacy) impacting the growth of the Telehealth and Telemedicine market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, delivery mode, therapeutic area, application, functionality, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient engagement solutions market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Patient Engagement Market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONAL SEGMENTATION
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
  • 2.1.3 PRIMARY SOURCES
  • 2.1.4 KEY DATA FROM PRIMARY SOURCES
  • 2.1.5 KEY INDUSTRY INSIGHTS
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• 2.3 MARKET ESTIMATION
  • 2.3.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
  • 2.3.2 APPROACH: END USER-BASED MARKET ESTIMATION
  • FIGURE 4 RESEARCH METHODOLOGY: MARKET ESTIMATION
  • 2.3.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
  • 2.3.4 TOP-DOWN APPROACH
  • 2.3.5 BOTTOM-UP APPROACH
  • FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2023-2028)
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
• 2.5 ASSUMPTIONS
• 2.6 LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT
  • TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
• 2.8 PATIENT ENGAGEMENT SOLUTIONS MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

• FIGURE 8 SOFTWARE TO BE LARGEST SEGMENT DURING FORECAST PERIOD
• FIGURE 9 CLOUD-BASED/WEB-BASED MODE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 10 HEALTH MANAGEMENT TO DOMINATE PATIENT ENGAGEMENT SOLUTIONS MARKET DURING FORECAST PERIOD
• FIGURE 11 PROVIDER TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
• FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT ENGAGEMENT SOLUTIONS MARKET

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
  • FIGURE 13 GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE TO DRIVE MARKET
• 4.2 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2022)
  • FIGURE 14 ON-PREMISE MODE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
• 4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 15 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: REGIONAL MIX
  • FIGURE 16 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• 4.5 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 5.2.1 DRIVERS
    • 5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
    • 5.2.1.2 Increasing adoption of patient engagement solutions
    • 5.2.1.3 Rising number of collaborations and partnerships between stakeholders
  • TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2023
    • 5.2.1.4 Increasing utilization of mobile health apps
    • 5.2.1.5 Rising geriatric population and subsequent increase in prevalence of chronic diseases
  • FIGURE 19 GERIATRIC POPULATION, BY REGION, 2010-2030 (% OF TOTAL POPULATION)
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Large investment requirements for healthcare infrastructure
    • 5.2.2.2 Protection of patient information
  • FIGURE 20 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES IN 2021
    • 5.2.2.3 Inadequate interoperability across healthcare providers
    • 5.2.2.4 Shortage of skilled IT professionals in healthcare industry
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging markets
    • 5.2.3.2 Wearable health technology
    • 5.2.3.3 Cloud-computing solutions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High deployment costs of healthcare IT systems
    • 5.2.4.2 Low levels of healthcare literacy
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 21 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
• 5.4 INDUSTRY TRENDS
  • 5.4.1 AI-DRIVEN DIGITAL TRANSFORMATION TO DRIVE NEXT WAVE OF PATIENT ENGAGEMENT
  • 5.4.2 REAL-TIME REMOTE DIAGNOSIS TO BE INTEGRAL PART OF PATIENT ENGAGEMENT
  • 5.4.3 ROLE OF MHEALTH IN PATIENT ENGAGEMENT
  • 5.4.4 GROWING ADOPTION OF TELEMEDICINE
  • 5.4.5 RISE OF SMART HOSPITAL ROOMS AND BEDSIDE TABLETS
  • 5.4.6 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
  • 5.6.1 RESEARCH AND DEVELOPMENT
  • 5.6.2 MATERIAL COMPONENTS
  • 5.6.3 MANUFACTURERS AND DEVELOPERS
  • 5.6.4 DISTRIBUTION AND SALES
  • 5.6.5 END-USER INDUSTRIES
  • 5.6.6 POST-SALE SERVICES
  • FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
  • 5.7.2 VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR)
  • 5.7.3 REMOTE MONITORING DEVICES AND WEARABLES
• 5.8 TARIFF AND REGULATORY ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 NORTH AMERICA
    • 5.8.2.1 US
      • 5.8.2.1.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
      • 5.8.2.1.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECh)
      • 5.8.2.1.3 Consumer Privacy Protection Act of 2017
      • 5.8.2.1.4 Affordable Care Act, 2010
    • 5.8.2.2 Canada
      • 5.8.2.2.1 Personal Information Protection and Electronic Documents Act (PIPEDA)
  • 5.8.3 EUROPE
    • 5.8.3.1 General Data Protection Regulation (GDPR), European Union (EU)
    • 5.8.3.2 EU Cybersecurity Act
    • 5.8.3.3 Germany
      • 5.8.3.3.1 German Data Protection Act (Bundesdatenschutzgesetz, BDSG)
    • 5.8.3.4 France
      • 5.8.3.4.1 French Data Protection Act
    • 5.8.3.5 Italy
      • 5.8.3.5.1 Personal Data Protection Code (Legislative Decree 196/2003)
  • 5.8.4 ASIA PACIFIC
    • 5.8.4.1 China
      • 5.8.4.1.1 Cybersecurity Law of People's Republic of China
    • 5.8.4.2 Japan
      • 5.8.4.2.1 Act on Protection of Personal Information (APPI)
    • 5.8.4.3 India
      • 5.8.4.3.1 The Information Technology Act, 2000
  • 5.8.5 LATIN AMERICA
    • 5.8.5.1 Protection of Personal Information Act
  • 5.8.6 MIDDLE EAST & AFRICA
    • 5.8.6.1 Private Cloud Computing Regulatory Framework
• 5.9 PRICING ANALYSIS
  • 5.9.1 PRICING OVERVIEW
  • FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET: PRICING COMPONENTS
  • 5.9.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • TABLE 7 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • 5.9.3 INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS
  • TABLE 8 INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS
• 5.10 TRADE ANALYSIS
  • FIGURE 26 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND)
  • FIGURE 27 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND)
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11.2 BARGAINING POWER OF SUPPLIERS
  • 5.11.3 BARGAINING POWER OF BUYERS
  • 5.11.4 THREAT OF NEW ENTRANTS
  • 5.11.5 THREAT OF SUBSTITUTES
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS
  • FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012-NOVEMBER 2023)
  • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATIENT ENGAGEMENT SOLUTIONS (JANUARY 2012-NOVEMBER 2023)
  • FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT ENGAGEMENT SOLUTIONS PATENTS DOCUMENTS
  • TABLE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET: LIST OF MAJOR PATENTS
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) FOR PATIENT ENGAGEMENT SOLUTIONS
  • 5.13.2 BUYING CRITERIA
  • FIGURE 32 KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTIONS
  • TABLE 13 KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTION COMPONENTS
• 5.14 END USER ANALYSIS
  • 5.14.1 UNMET NEEDS
  • TABLE 14 UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 5.14.2 END USER EXPECTATIONS
  • TABLE 15 END USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
• 5.15 KEY CONFERENCES & EVENTS IN 2023-2024
  • TABLE 16 PATIENT ENGAGEMENT SOLUTIONS: DETAILED LIST OF CONFERENCES & EVENTS
• 5.16 REPLACEMENT TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS
• 5.17 PATIENT ENGAGEMENT SOLUTIONS INVESTMENT LANDSCAPE
  • FIGURE 33 INVESTOR DEALS AND FUNDING IN PATIENT ENGAGEMENT SOLUTIONS SOARED IN 2022
  • FIGURE 34 MOST VALUED PATIENT ENGAGEMENT SOLUTION FIRMS IN 2022 (USD BILLION)
• 5.18 PATIENT ENGAGEMENT SOLUTIONS BUSINESS MODELS
  • 5.18.1 SUBSCRIPTION-BASED MODEL
  • 5.18.2 LICENSING MODEL
  • 5.18.3 HYBRID MODEL
  • 5.18.4 FREEMIUM MODEL
  • 5.18.5 VALUE-BASED PRICING MODEL
  • 5.18.6 DATA MONETIZATION
  • 5.18.7 CUSTOM DEVELOPMENT/CONSULTING MODEL
  • 5.18.8 INTEGRATION WITH EXISTING SYSTEMS
  • 5.18.9 PARTNERSHIPS WITH HEALTHCARE PROVIDERS
  • 5.18.10 WHITE-LABEL SOLUTIONS
  • 5.18.11 OPEN-SOURCE SOFTWARE
• 5.19 USE CASES/CASE STUDIES
  • 5.19.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
    • 5.19.1.1 Use case 1: Need to reduce patient hospital stays
  • 5.19.2 IMPROVE OUTPATIENT COMMUNICATION
    • 5.19.2.1 Case 2: Rising need to curb miscommunication with discharged patients
  • 5.19.3 PATIENT ENGAGEMENT STRATEGY
    • 5.19.3.1 Use case 3: Post-discharge care
  • 5.19.4 AN EMR-AGNOSTIC PATIENT ENGAGEMENT PLATFORM WITH COMPREHENSIVE BUILT-IN CAPABILITIES
    • 5.19.4.1 Use case 4: To improve patient engagement, giving patients ability to access all their medical information in one place

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

• 6.1 INTRODUCTION
  • TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
• 6.2 HARDWARE
  • 6.2.1 INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
  • TABLE 18 HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 19 HARDWARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 21 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 23 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.2 IN-ROOM TELEVISIONS
    • 6.2.2.1 Increase in adoption of in-room televisions by hospitals
  • TABLE 25 IN-ROOM TELEVISIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 27 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.3 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
    • 6.2.3.1 Integrated bedside terminals enhance patient experience
  • TABLE 31 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 33 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 36 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.4 TABLETS
    • 6.2.4.1 Portability and cost-effectiveness of tablets support growth
  • TABLE 37 TABLETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 41 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 42 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 SOFTWARE
  • TABLE 43 SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 44 SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 48 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.1 STANDALONE SOFTWARE
    • 6.3.1.1 Standalone software refers to traditional software installed in client systems
  • TABLE 50 STANDALONE SOLUTIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 52 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.2 INTEGRATED SOFTWARE
    • 6.3.2.1 Reduction in time spent on data management to drive growth
  • TABLE 56 INTEGRATED SOLUTIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 60 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 61 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.4 SERVICES
  • TABLE 62 SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 63 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 66 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 67 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE

• 7.1 INTRODUCTION
  • TABLE 68 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
• 7.2 ON-PREMISE MODE
  • 7.2.1 PATIENT DATA SAFETY AND COST BENEFITS TO DRIVE MARKET
  • TABLE 69 ON-PREMISE MODE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 70 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 73 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 CLOUD-BASED/ WEB-BASED MODE
  • 7.3.1 REGULATORY REQUIREMENTS DRIVE HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
  • TABLE 75 CLOUD-BASED/WEB-BASED MODE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 79 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021-2028 (USD MILLION)

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 81 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 HEALTH MANAGEMENT
  • 8.2.1 HEALTH MANAGEMENT PLAYS CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
  • TABLE 82 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 83 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 84 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 86 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 HOME HEALTH MANAGEMENT
  • 8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT MARKET GROWTH
  • TABLE 88 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 89 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 90 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 92 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 SOCIAL & BEHAVIORAL MANAGEMENT
  • 8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE MARKET GROWTH
  • TABLE 94 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 96 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 98 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.5 FINANCIAL HEALTH MANAGEMENT
  • 8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
  • TABLE 100 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 102 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 104 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA

• 9.1 INTRODUCTION
  • TABLE 106 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
• 9.2 CHRONIC DISEASES
  • TABLE 107 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 108 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 109 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 110 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 112 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.2.1 CARDIOVASCULAR DISEASES (CVD)
    • 9.2.1.1 Leading cause of death worldwide
  • TABLE 114 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 115 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 116 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 118 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 119 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.2.2 DIABETES
    • 9.2.2.1 High incidence of diabetes worldwide drives growth
  • TABLE 120 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 121 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 122 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 124 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 125 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.2.3 OBESITY
    • 9.2.3.1 Rising prevalence of obesity to drive growth
  • TABLE 126 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 127 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 128 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.2.4 OTHER CHRONIC DISEASES
  • TABLE 132 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 133 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 134 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 136 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 WOMEN'S HEALTH
  • 9.3.1 INCREASING SELF-AWARENESS FOR MANAGEMENT OF DISEASES TO DRIVE MARKET
  • TABLE 138 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 139 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 140 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 142 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 FITNESS
  • 9.4.1 GROWING PREFERENCE FOR HEALTHY LIFESTYLE TO SUPPORT MARKET GROWTH
  • TABLE 144 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 145 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 146 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 148 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.5 OTHER THERAPEUTIC AREAS
  • TABLE 150 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 151 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 152 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 154 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

• 10.1 INTRODUCTION
  • TABLE 156 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
• 10.2 PATIENT/CLIENT SCHEDULING
  • 10.2.1 STREAMLINING OF WORKFLOWS AND EFFICIENT MANAGEMENT OF PATIENT SCHEDULES
  • TABLE 157 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 158 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 159 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 161 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 162 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021-2028 (USD MILLION)
• 10.3 TELEHEALTH
  • 10.3.1 FLEXIBILITY IN TREATMENT OPTIONS DUE TO REMOTE MONITORING
  • TABLE 163 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 164 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 165 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 167 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
• 10.4 E-PRESCRIBING
  • 10.4.1 COST-EFFECTIVE METHOD TO ENHANCE DECISION-MAKING
  • TABLE 169 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 171 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021-2028 (USD MILLION)

• 10.5 DOCUMENT MANAGEMENT
  • 10.5.1 EFFECTIVE MANAGEMENT OF PATIENT DOCUMENTS CRUCIAL FOR HEALTHCARE PROVIDERS
  • TABLE 175 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 176 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 177 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 179 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
• 10.6 BILLING & PAYMENTS
  • 10.6.1 DEMAND FOR STREAMLINED PROCESSES TO DRIVE MARKET GROWTH
  • TABLE 181 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 182 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 183 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 185 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 186 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
• 10.7 PATIENT EDUCATION
  • 10.7.1 RISING DEMAND FOR INFORMED HEALTHCARE TO DRIVE MARKET GROWTH
  • TABLE 187 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 188 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 189 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 191 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
• 10.8 OTHER FUNCTIONALITIES
  • TABLE 193 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 194 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 195 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 197 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021-2028 (USD MILLION)

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

• 11.1 INTRODUCTION
  • TABLE 199 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 11.2 PROVIDERS
  • 11.2.1 LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
  • TABLE 200 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 201 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 202 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 203 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 205 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.2.2 HOSPITALS & HEALTHCARE SYSTEMS
    • 11.2.2.1 Hospitals and healthcare systems contribute highest share
  • TABLE 207 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 208 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 209 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 211 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.2.3 AMBULATORY CARE CENTERS
    • 11.2.3.1 Gradual shift of patient care from inpatient to outpatient settings to drive growth
  • TABLE 213 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 214 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 215 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 217 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.2.4 HOME CARE CENTERS
    • 11.2.4.1 Rise in global geriatric population requiring long-term care to support market growth
  • TABLE 219 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 220 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 221 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 223 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.2.5 OTHER PROVIDERS
  • TABLE 225 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 226 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 227 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 228 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 229 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 11.3 PAYERS
  • 11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
  • TABLE 231 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 232 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 233 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 234 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 236 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3.2 PRIVATE
    • 11.3.2.1 Private payers partnering with telehealth vendors for seamless healthcare solutions
  • TABLE 238 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 239 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 240 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 242 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3.3 PUBLIC
    • 11.3.3.1 Investments made by public payers to support market
  • TABLE 244 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 245 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 246 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 248 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 11.4 PATIENTS
  • 11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR AND IMPROVE HEALTH OUTCOMES
  • TABLE 250 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 251 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 252 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 254 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 255 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
• 11.5 OTHER END USERS
  • TABLE 256 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 257 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 258 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 260 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 261 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

• 12.1 INTRODUCTION
  • TABLE 262 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 12.2 NORTH AMERICA
  • FIGURE 35 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
  • 12.2.1 RECESSION IMPACT
  • TABLE 263 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 264 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 265 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 266 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 267 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 268 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 269 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 270 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 271 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 272 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 273 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 274 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.2.2 US
    • 12.2.2.1 High healthcare expenditure and affordable costs to drive market
  • TABLE 275 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 276 US: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 277 US: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 278 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 279 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 280 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 281 US: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 282 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 283 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 284 US: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 285 US: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.2.3 CANADA
    • 12.2.3.1 Growing need for cost containment to drive market
  • TABLE 286 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 287 CANADA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 288 CANADA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 289 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 290 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 291 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 292 CANADA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 293 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 294 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 295 CANADA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 296 CANADA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 12.3 EUROPE
  • 12.3.1 RECESSION IMPACT
  • TABLE 297 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 298 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 299 EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 300 EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 301 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 302 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 303 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 304 EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 305 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 306 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 307 EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 308 EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.2 GERMANY
    • 12.3.2.1 Growing demand for effective patient records management to drive market
  • TABLE 309 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 310 GERMANY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 311 GERMANY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 312 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 313 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 314 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 315 GERMANY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 316 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 317 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 318 GERMANY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 319 GERMANY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.3 FRANCE
    • 12.3.3.1 Digital health insurance startups to drive market
  • TABLE 320 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 321 FRANCE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 322 FRANCE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 323 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 324 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 325 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 326 FRANCE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 327 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 328 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 329 FRANCE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 330 FRANCE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.4 UK
    • 12.3.4.1 Favorable government initiatives promoting healthcare to drive market
  • TABLE 331 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 332 UK: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 333 UK: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 334 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 335 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 336 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 337 UK: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 338 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 339 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 340 UK: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 341 UK: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.5 SPAIN
    • 12.3.5.1 Enhanced ability for monitoring patients and chronic illnesses to drive market
  • TABLE 342 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 343 SPAIN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 344 SPAIN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 345 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 346 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 347 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 348 SPAIN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 349 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 350 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 351 SPAIN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 352 SPAIN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.6 ITALY
    • 12.3.6.1 Growing burden of chronic diseases and shortage of healthcare workers to drive market
  • TABLE 353 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 354 ITALY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 355 ITALY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 356 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 357 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 358 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 359 ITALY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 360 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 361 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 362 ITALY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 363 ITALY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3.7 REST OF EUROPE
  • TABLE 364 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 365 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 366 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 367 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 368 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 369 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 370 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 371 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 372 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 373 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 374 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)

• 12.4 ASIA PACIFIC
  • 12.4.1 RECESSION IMPACT
  • FIGURE 36 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
  • TABLE 375 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 376 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 378 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 380 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 384 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.4.2 JAPAN
    • 12.4.2.1 Rising geriatric population to drive market
  • TABLE 387 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 388 JAPAN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 389 JAPAN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 390 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 391 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 392 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 393 JAPAN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 394 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 395 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 396 JAPAN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 397 JAPAN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.4.3 CHINA
    • 12.4.3.1 Implementation of EMR solutions by government to drive market
  • TABLE 398 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 399 CHINA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 400 CHINA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 401 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 402 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 403 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 404 CHINA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 405 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 406 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 407 CHINA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 408 CHINA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.4.4 INDIA
    • 12.4.4.1 High burden of chronic diseases to drive market
  • TABLE 409 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 410 INDIA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 411 INDIA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 412 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 413 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 414 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 415 INDIA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 416 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 417 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 418 INDIA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 419 INDIA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.4.5 REST OF ASIA PACIFIC
  • TABLE 420 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 421 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 422 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 423 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 424 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 426 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 427 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 428 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 429 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 430 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 12.5 LATIN AMERICA
  • 12.5.1 RECESSION IMPACT
  • TABLE 431 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 432 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 433 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 434 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 435 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 436 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 437 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 438 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 439 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 440 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 441 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 442 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.5.2 BRAZIL
    • 12.5.2.1 Growing emphasis on reducing healthcare costs to drive market
  • TABLE 443 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 444 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 445 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 446 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 447 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 448 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 449 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 450 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 451 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 452 BRAZIL: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 453 BRAZIL: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.5.3 MEXICO
    • 12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market
  • TABLE 454 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 455 MEXICO: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 456 MEXICO: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 457 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 458 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 459 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 460 MEXICO: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 461 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 462 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 463 MEXICO: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 464 MEXICO: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.5.4 REST OF LATIN AMERICA
  • TABLE 465 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 466 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 467 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 468 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 469 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 470 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 471 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 472 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 473 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 474 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 475 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 RECESSION IMPACT
  • TABLE 476 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 477 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 478 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 479 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 480 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 481 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 482 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 483 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 484 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 485 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 486 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 487 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Initiatives for improving present health infrastructure to drive market
  • TABLE 488 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 489 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 490 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 491 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 492 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 493 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 494 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 495 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 496 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 497 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 498 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.6.3 REST OF MIDDLE EAST & AFRICA
  • TABLE 499 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • TABLE 500 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 501 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 502 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • TABLE 503 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 504 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
  • TABLE 505 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 506 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION)
  • TABLE 507 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 508 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 509 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021-2028 (USD MILLION)

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 510 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
• 13.3 REVENUE ANALYSIS
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
• 13.4 MARKET SHARE ANALYSIS
  • FIGURE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET: MARKET SHARE ANALYSIS (2022)
  • TABLE 511 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION
  • FIGURE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET: RANKING OF KEY COMPANIES (2022)
• 13.5 COMPANY EVALUATION MATRIX
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • FIGURE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 13.5.5 COMPANY FOOTPRINT
  • TABLE 512 COMPANY FOOTPRINT (14 COMPANIES)
  • TABLE 513 COMPONENT FOOTPRINT (14 COMPANIES)
  • TABLE 514 APPLICATION FOOTPRINT (14 COMPANIES)
  • TABLE 515 REGIONAL FOOTPRINT (14 COMPANIES)
• 13.6 START-UP/SME EVALUATION MATRIX
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 DYNAMIC COMPANIES
  • 13.6.3 RESPONSIVE COMPANIES
  • 13.6.4 STARTING BLOCKS
  • FIGURE 41 PATIENT ENGAGEMENT SOLUTIONS MARKET: STARTUP/SME EVALUATION MATRIX (2022)
  • 13.6.5 COMPETITIVE BENCHMARKING
  • TABLE 516 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 517 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
• 13.7 COMPETITIVE SITUATIONS AND TRENDS
  • 13.7.1 PRODUCT LAUNCHES/ENHANCEMENT
  • TABLE 518 PRODUCT LAUNCHES/ENHANCEMENT, 2020-2023
  • 13.7.2 DEALS
  • TABLE 519 DEALS, 2020-2023
  • 13.7.3 OTHER DEVELOPMENTS
  • TABLE 520 OTHER DEVELOPMENTS, (2020-2023)

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 14.1.1 MCKESSON CORPORATION
• TABLE 521 MCKESSON CORPORATION: COMPANY OVERVIEW
• FIGURE 42 MCKESSON CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 522 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 523 MCKESSON CORPORATION: PRODUCT LAUNCHES
• TABLE 524 MCKESSON CORPORATION: DEALS
• TABLE 525 MCKESSON CORPORATION: OTHER DEVELOPMENTS
• 14.1.2 ORACLE CORPORATION
• TABLE 526 ORACLE CORPORATION: COMPANY OVERVIEW
• FIGURE 43 ORACLE CORPORATION: COMPANY SNAPSHOT (2023)
• TABLE 527 ORACLE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 528 ORACLE CORPORATION: PRODUCT DEVELOPMENTS
• TABLE 529 ORACLE CORPORATION: DEALS
• 14.1.3 VERADIGM LLC
• TABLE 530 VERADIGM LLC: COMPANY OVERVIEW
• FIGURE 44 VERADIGM LLC: COMPANY SNAPSHOT (2021)
• TABLE 531 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 532 VERADIGM LLC: PRODUCT LAUNCHES
• TABLE 533 VERADIGM LLC: DEALS
• TABLE 534 VERADIGM LLC: OTHER DEVELOPMENTS
• 14.1.4 ATHENAHEALTH
• TABLE 535 ATHENAHEALTH: COMPANY OVERVIEW
• TABLE 536 ATHENAHEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 537 ATHENAHEALTH: PRODUCT ENHANCEMENT
• TABLE 538 ATHENAHEALTH: DEALS
• TABLE 539 ATHENAHEALTH: OTHER DEVELOPMENTS
• 14.1.5 ORION HEALTH
• TABLE 540 ORION HEALTH: COMPANY OVERVIEW
• TABLE 541 ORION HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 542 ORION HEALTH: PRODUCT LAUNCHES
• TABLE 543 ORION HEALTH: DEALS
• TABLE 544 ORION HEALTH: OTHER DEVELOPMENTS
• 14.1.6 GETWELLNETWORK, INC.
• TABLE 545 GETWELLNETWORK, INC.: COMPANY OVERVIEW
• TABLE 546 GETWELLNETWORK, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 547 GETWELLNETWORK, INC.: PRODUCT LAUNCHES
• TABLE 548 GETWELLNETWORK, INC.: DEALS
• TABLE 549 GETWELLNETWORK, INC.: OTHER DEVELOPMENTS
• 14.1.7 LINCOR INC.
• TABLE 550 LINCOR INC.: COMPANY OVERVIEW
• TABLE 551 LINCOR INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 552 LINCOR INC.: OTHER DEVELOPMENTS
• 14.1.8 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
• TABLE 553 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY OVERVIEW
• FIGURE 45 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 554 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
• TABLE 555 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: OTHER DEVELOPMENTS
• 14.1.9 GET REAL HEALTH
• TABLE 556 GET REAL HEALTH: COMPANY OVERVIEW
• TABLE 557 GET REAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 558 GET REAL HEALTH: PRODUCT LAUNCHES
• TABLE 559 GET REAL HEALTH: OTHER DEVELOPMENTS
• 14.1.10 ONEVIEW HEALTHCARE
• TABLE 560 ONEVIEW HEALTHCARE: COMPANY OVERVIEW
• FIGURE 46 ONEVIEW HEALTHCARE: COMPANY SNAPSHOT (2022)
• TABLE 561 ONEVIEW HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 562 ONEVIEW HEALTHCARE: PRODUCT LAUNCH/ENHANCEMENT
• TABLE 563 ONEVIEW HEALTHCARE: DEALS
• TABLE 564 ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS
• 14.1.11 ADVANCEDMD, INC.
• TABLE 565 ADVANCEDMD, INC.: COMPANY OVERVIEW
• TABLE 566 ADVANCEDMD, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 14.1.12 EPIC SYSTEMS CORPORATION
• TABLE 567 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
• TABLE 568 EPIC SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 569 EPIC SYSTEMS CORPORATION: DEALS
• 14.1.13 HARRIS HEALTHCARE
• TABLE 570 HARRIS HEALTHCARE: COMPANY OVERVIEW
• TABLE 571 HARRIS HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 572 HARRIS HEALTHCARE: DEALS
• TABLE 573 HARRIS HEALTHCARE: OTHER DEVELOPMENTS
• 14.1.14 MEDICAL INFORMATION TECHNOLOGY, INC.
• TABLE 574 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
• TABLE 575 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 576 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS
• TABLE 577 MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 14.2 OTHER PLAYERS
  • 14.2.1 KAREO, INC.
  • 14.2.2 ECLINICAL WORKS
  • 14.2.3 WELLSTACK
  • 14.2.4 IQVIA HOLDINGS INC.
  • 14.2.5 VIVIFY HEALTH
  • 14.2.6 MEDHOST
  • 14.2.7 LUMA HEALTH
  • 14.2.8 CUREMD HEALTHCARE
  • 14.2.9 SONIFI HEALTH
  • 14.2.10 ADVANTECH CO., LTD.
  • 14.2.11 BARCO

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료